Kidney Week

Oral Abstract Session

Peritoneal Dialysis and Vascular Access: Research Abstracts

October 25, 2020 | 05:00 PM - 07:00 PM

Location: Simulive

Session Description

Oral Abstract Session

Learning Pathway(s)

• Dialysis

Moderators

• Marjorie Wai Yin Foo, MBChB, FASN
• Lalathaksha Murthy Kumbar, MBBS

Presentations

• Variation in Peritoneal Dialysis-Related Peritonitis Outcomes and Treatment Practices: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study
  05:00 PM - 07:00 PM
  Muthana Al sahlawi, MD 
  
  Muthana Al sahlawi, MD

  Muthana Al Sahlawi is a nephrologist and Assistant Professor of Medicine at King Faisal University, Saudi Arabia. He completed his residency training in internal medicine at National Guard hospital, Saudi Arabia in 2015. Following this, he joined University of Toronto, where he completed 3 years of clinical training in adult Nephrology and Home Dialysis. Dr. Alsahlawi’s primary research interests and clinical practice focuses on improving peritoneal dialysis utilization and outcomes. Recent publications Al Sahlawi M, Bargman JM, Perl J. Peritoneal Dialysis-Associated Peritonitis: Suggestions for Management and Mistakes to Avoid. Kidney Med. 2020;2(4):467-475. Published 2020 Jul 3. doi:10.1016/j.xkme.2020.04.010 Sahlawi, M. A., Wilson, G., Stallard, B., Manera, K. E., Tong, A., Pisoni, R. L., Fuller, D. S., Cho, Y., Johnson, D. W., Piraino, B., Schreiber, M. J., Boudville, N. C., Teitelbaum, I., & Perl, J. (2020). Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 40(2), 132–140. https://doi.org/10.1177/0896860819893810 Al Sahlawi M, Liew A, Perl J. Cefepime as Empirical Peritoneal Dialysis-Associated Peritonitis Treatment: Something to Dwell On? Am J Kidney Dis. 2019;74(5):579-582. doi:10.1053/j.ajkd.2019.06.008 Glavinovic T, Kashani M, Al-Sahlawi M, et al. A Peritoneal Dialysis Access Quality Improvement Initiative: A Single-Center Experience. Perit Dial Int. 2019;39(5):437-446. doi:10.3747/pdi.2018.00233 Abdelgadir E, Al Sahlawi M, Al Turki L, Khamees K, Ahmed W. Identification of a new homozygous CEP290 gene mutation in a Saudi Family causing joubert syndrome using next-generation sequencing. Saudi J Kidney Dis Transpl. 2019;30(4):964-968. doi:10.4103/1319-2442.265475

Variation in Peritoneal Dialysis-Related Peritonitis Outcomes and Treatment Practices: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Rate of Decline in Residual Kidney Function Before and After Peritoneal Dialysis Initiation: A Post Hoc Analysis of the IDEAL Study
  05:00 PM - 07:00 PM
  Isabelle Ethier, MD 
  
  

  Isabelle Ethier, MD

  Dr Isabelle Ethier has completed her medical training (2013) and residency program in Adult Nephrology (2018) at Université de Montréal, in Canada. She is currently appointed as a Nephrology Fellow at the Princess Alexandra Hospital, in Brisbane, Australia, where she is pursuing research and clinical work in home dialysis. She is also enrolled in a Master's degree in Biomedical Sciences -- Applied Clinical Research at Université de Montréal.

Rate of Decline in Residual Kidney Function Before and After Peritoneal Dialysis Initiation: A Post Hoc Analysis of the IDEAL Study

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Steady Concentration Peritoneal Dialysis Increases Ultrafiltration and Sodium Removal Compared with Continuous Ambulatory Peritoneal Dialysis (CAPD)
  05:00 PM - 07:00 PM
  Olof Heimburger, MD, PhD 
  
  

  Olof Heimburger, MD, PhD

  Olof Heimbürger short CV Olof Heimbürger (born 1957), MD, PhD, Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet. Senior Physician, Medical Unit Renal Medcine Karolinska University Hospital, Huddinge and Solna, Stockholm, Sweden. Ph D Thesis (1994): “Peritoneal transport in patients treated with continuous peritoneal dialysis”. I have more that 30 years of clinical nephrology experience and has published more than 350 papers and textbook chapters on peritoneal dialysis, nutrition, inflammation and cardiovascular disease in patients with chronic renal failure. I was a council member of the International Society for Peritoneal Dialysis 2001-2014 and a member of the European Renal Best Practice (ERBP, the guidline committee of ERA-EDTA) advisory board 2008-2020.

Steady Concentration Peritoneal Dialysis Increases Ultrafiltration and Sodium Removal Compared with Continuous Ambulatory Peritoneal Dialysis (CAPD)

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Efficacy and Safety of Roxadustat in Patients with Dialysis-Dependent CKD and Anemia on Peritoneal Dialysis
  05:00 PM - 07:00 PM
  Tak Mao Daniel Chan, MD, FASN 
  
  

  Tak Mao Daniel Chan, MD, FASN

  Daniel Tak Mao Chan obtained his MBBS, MD, and DSc degrees from the University of Hong Kong (HKU). He is Chair Professor at the HKU Department of Medicine, Queen Mary Hospital, and Chief of Nephrology for HK West Cluster Hospitals. He is also the Yu Chiu Kwong Endowed Professor in Medicine. He has previously served as President of the Asian Pacific Society of Nephrology (APSN), and is currently Vice-President of Hong Kong College of Physicians. He is recipient of APSN Kenzo Oshima Award. His research interests include 'lupus nephritis' and 'viral hepatitis in patients with kidney diseases'.

Efficacy and Safety of Roxadustat in Patients with Dialysis-Dependent CKD and Anemia on Peritoneal Dialysis

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis
  05:00 PM - 07:00 PM
  Matthew B. Rivara, MD, FASN 
  
  

  Matthew B. Rivara, MD, FASN

  Dr. Matthew Rivara is Assistant Professor of Medicine in the Division of Nephrology at the University of Washington. He is currently an investigator at the Kidney Research Institute at the University of Washington. Dr. Rivara received his M.D. from Harvard Medical School, and completed a residency in internal medicine at the Massachusetts General Hospital, as well as a clinical and research fellowship in nephrology at the University of Washington. His current research interests focus on patient-reported outcomes in kidney disease, and the growing utilization of home dialysis therapies in the United States.

Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Cardiovascular Thromboembolic Outcomes by Dialysis Modality Following Primary Total Knee Arthroplasty
  05:00 PM - 07:00 PM
  Chavely Valdes Sanchez, MD 
  
  

  Chavely Valdes Sanchez, MD

  Chavely Valdes Sanchez is currently completing her second year of Internal Medicine Residency at the University of Miami/Holy Cross Hospital in Fort Lauderdale, FL. She attended medical school at The Pennsylvania State University in Hershey, PA and received her B.S. in Biological Sciences at Florida International University in Miami, FL. Dr. Valdes Sanchez previously conducted research as part of Howard Hughes Medical Institute EXROP and MARC U*STAR programs. Her future plans include completing a nephrology fellowship.

Cardiovascular Thromboembolic Outcomes by Dialysis Modality Following Primary Total Knee Arthroplasty

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Prognostic Roles of Peritoneal Dialysis Effluent Mitochondrial DNA Level
  05:00 PM - 07:00 PM
  Win Hlaing Than, MBBS, MS 
  
  

  Win Hlaing Than, MBBS, MS

  ASNID 663132 PhD (Medical Sciences) student Li Ka Shing Institute of Health Sciences (LiHS), Faculty of Medicine, The Chinese University of Hong Kong. Carol & Richard Yu Peritoneal Dialysis Research Centre, Department of Medicine & Therapeutics, Prince of Wales Hospital, Hong Kong.

Prognostic Roles of Peritoneal Dialysis Effluent Mitochondrial DNA Level

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Hemodynamics and Geometry of Rat Arteriovenous Fistulas: Effect of Sildenafil Treatment
  05:00 PM - 07:00 PM
  Hannah M. Northrup 
  
  

  Hannah M. Northrup

  I am a PhD candidate in Biomedical Engineering at the University of Utah in Dr. Yan-Ting Shiu's lab. I received my Master's in Biomedical Engineering from the University of Utah in 2019 and a Bachelor's in Biochemisty in 2015 from Brigham Young University-Hawaii.

Hemodynamics and Geometry of Rat Arteriovenous Fistulas: Effect of Sildenafil Treatment

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Single-Center Real-World Experience with Endovascular Arteriovenous Fistulas
  05:00 PM - 07:00 PM
  Kareem Genena, MBChB 
  
  

  Kareem Genena, MBChB

  Second year nephrology fellow at the Baylor University Medical Center at Dallas, TX. Graduated from the Alexandria University, Faculty of Medicine in Egypt.

Single-Center Real-World Experience with Endovascular Arteriovenous Fistulas

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Association Between Antimicrobial Barrier Cap Use and Outcomes Among Hemodialysis Patients Using a Central Venous Catheter
  05:00 PM - 07:00 PM
  Scott Sibbel, PhD
  
  Scott Sibbel, PhD

Association Between Antimicrobial Barrier Cap Use and Outcomes Among Hemodialysis Patients Using a Central Venous Catheter

October 25, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.